Oxidized DNA Bases in Breast Cancer
Abstract
Recently more studies have correlated the elevated 5-hydroxymethyl-2'-deoxyuridine (HMdU - an oxidized DNA base) levels with an increased risk of cancer when compared to controls. HMdU has been proposed to be a biomarker for breast cancer risk Although methods are available, but requires larger sample sizes (between 50- 100 micrograms DNA), which limits its application for HMdU quantitation in relatively smaller sample size We have developed a sensitive method to detect and quantitate HMdU using fluorescent coumarin derivative to label HMdU and other nucleosides.
Document Details
- Document Type
- Technical Report
- Publication Date
- Aug 01, 2002
- Accession Number
- ADA413879
Entities
People
- Krystyna Frenkel
- Mehul Desai
Organizations
- New York University